TROMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tromethamine, and when can generic versions of Tromethamine launch?
Tromethamine is a drug marketed by B Braun Medical and Milla Pharms and is included in two NDAs.
The generic ingredient in TROMETHAMINE is tromethamine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the tromethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tromethamine
A generic version of TROMETHAMINE was approved as tromethamine by B BRAUN MEDICAL on December 9th, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TROMETHAMINE?
- What are the global sales for TROMETHAMINE?
- What is Average Wholesale Price for TROMETHAMINE?
Summary for TROMETHAMINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 300 |
| Clinical Trials: | 92 |
| Patent Applications: | 3,749 |
| DailyMed Link: | TROMETHAMINE at DailyMed |
Recent Clinical Trials for TROMETHAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| SYED HAIDER ALI | NA |
| Al-Azhar University | EARLY_PHASE1 |
| Tanta University | PHASE1 |
Medical Subject Heading (MeSH) Categories for TROMETHAMINE
US Patents and Regulatory Information for TROMETHAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical | TROMETHAMINE | tromethamine | SOLUTION;INJECTION | 211558-001 | Dec 9, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Milla Pharms | TROMETHAMINE | tromethamine | SOLUTION;INJECTION | 213116-001 | Dec 31, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
